ImprimisRx NJ recalls
FDA enforcement reports naming ImprimisRx NJ as the recalling firm.
- Recall reports
- 4
- Class I (serious)
- 0
- Most recent report
- Sep 16, 2026
- Sep 16, 2026Povidone Iodine 1Drug · ImprimisRx NJ LLCSubpotent DrugClass III
- Nov 23, 2022Timolol-Latanoprost (0Drug · ImprimisRx NJSubpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.Class II
- Aug 7, 2019Timolol-Latanoprost P-F (0Drug · ImprimisRx NJSubpotent DrugClass II
- Aug 7, 2019Timolol- Dorzolamide- Latanoprost P-F (0Drug · ImprimisRx NJSubpotent DrugClass II